01783nam a2200361Ia 4500001000700000003000600007005001700013008004100030020001500071037002000086040001300106042000800119043001200127049001300139074001100152074001600163086002100179088008600200092002400286110011000310245030600420260008000726300002300806500006500829500003600894500006000930500002400990610008001014650005701094650005801151999001901209952019301228265929OCoLC20160527193411.0040504s2004    dcu          f000 0 eng c  a0160715121  a552-070-31083-5  aGPOcGPO  apcc  an-us---  aPUXAbev  a1027-A  a1027-B (MF)0 aY 4.V 64/3:108-4  aSerial no. 108-4 (United States. Congress. House. Committee on Veterans' Affairs)0 a344.04233bO9662221 aUnited StatesbCongress.bHouse.bCommittee on Veterans' Affairs.bSubcommittee on Health.2Local918291310aOversight hearing on the availability and eligibility for pharmaceutical services provided by the Department of Veterans Affairsbhearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Eight [sic] Congress, first session, March 19, 2003.  aWashingtonbU.S. G.P.O.bFor sale by the Supt. of Docs., U.S. G.P.O.c2004.  aiv, 102 p.c24 cm.  a"Printed for the use of the Committee on Veterans' Affairs."  aShipping list no.: 2004-0154-P.  aDistributed to some depository libraries in microfiche.  a"Serial no. 108-4."10aUnited StatesbDept. of Veterans Affairs.bPharmacy Service.2Local9182913 0aPharmaceutical policyzUnited States.2Local9150477 0aVeteransxMedical carezUnited States.2Local9185252  c191758d191758  00102ddc406344_042330000000000_O966708evl9206434a10b10c1d2016-05-27eFederal Depositoryh2003 Mar. 19i377121l0o344.04233 O966p80000002212515r2016-05-27 00:00:00xr:265929y6